Perspectives and Concerns Regarding Antimicrobial Agent Shortages Among Infectious Disease Specialists

Gundlapalli, Adi V.; Beekmann, Susan E.; Graham, Donald R.; Polgreen, Philip M.

doi:10.1016/j.diagmicrobio.2012.11.020

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Perspectives and Concerns Regarding Antimicrobial Agent Shortages Among Infectious Disease Specialists

Published Date:

Jan 08 2013

Publisher's site:

http://dx.doi.org/10.1016/j.diagmicrobio.2012.11.020 New Site Icon

Source:

Diagn Microbiol Infect Dis. 75(3):256-259.

[PDF-57.88 KB]

Details:

Personal Authors:

Gundlapalli, Adi V. ; Beekmann, Susan E. ; Graham, Donald R. ; Polgreen, Philip M. ;

Keywords:

[+]

Pubmed ID:

23305775

Pubmed Central ID:

PMC5815827

Description:

Antimicrobial shortages have made treating certain infections more difficult. A web-based survey asking about experience with antimicrobial drug shortages was distributed in 2011 to 1328 infectious diseases physician members of the Emerging Infectious Diseases Network of the Infectious Diseases Society of America. A majority (78%) of 627 respondents reported needing to modify antimicrobial choices because of drug shortages within the past 2 years. Antimicrobials most often reported as not available or available but in short supply were trimethoprim-sulfamethoxazole injection (by 65% of respondents), amikacin (by 58%), aztreonam (by 31%), and foscarnet (by 22%). Most respondents (55%) reporting a shortage indicated that the shortage adversely affected patient outcomes and that they were forced to use alternative and second line agents which were either less effective, more toxic, or more costly. Most (70%) indicated that they learned about the shortage from contact with the pharmacy after trying to prescribe a drug in short supply. More effective means of informing physicians about drug shortages is critical to lessen the impact on patient care.

Document Type:

Journal Article

Collection(s):

CDC Public Access

Funding:

U50 CCU112346/PHS HHS/United States
5P01HK000069/HK/PHITPO CDC HHS/United States
1 U54 A1065357/PHS HHS/United States
U54 AI065357/AI/NIAID NIH HHS/United States
P01 HK000069/HK/PHITPO CDC HHS/United States

Main Document Checksum:

[+]

Supporting Files:

nihms-426589.nxml

text/xml

No Related Documents.

You May Also Like:

The Infectious Diseases Society of America Emerging Infections Network: Bridging the Gap Between Clinical Infectious Diseases and Public Health

Personal Author:

Pillai, Satish K.; Beekmann, Susan E.; Santibanez, Scott; Polgreen, Philip M.;

Published:

Jan 07 2014

Source:

Clin Infect Dis. 58(7):991-996.

Description:

In 1995, the Centers for Disease Control and Prevention granted a Cooperative Agreement Program award to the Infectious Diseases Society of America to develop a provider-based emerging infections sentinel network, the Emerging Infections Network (EIN...

File Type:

[PDF - 275.08 KB]
Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers

Personal Author:

Harris, Aaron M.; Beekmann, Susan E.; Polgreen, Philip M.; Moore, Matthew R.;

Published:

May 17 2014

Source:

Diagn Microbiol Infect Dis. 79(4):454-457.

Description:

Streptococcus pneumoniae (pneumococcus) is the most common bacterial etiology of community-acquired pneumonia (CAP) in adults, a leading cause of death. The majority of pneumococcal CAP is diagnosed by blood culture, which likely underestimates the b...

File Type:

[PDF - 300.19 KB]
Record of the proceedings : meeting of the Advisory Council for the Elimination of Tuberculosis, April 26, 2016

Corporate Author:

Advisory Council for the Elimination of Tuberculosis (U.S.). Centers for Disease Control and Prevention (U.S.). National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Tuberculosis Elimination..

Published:

8/30/16

Description:

The US Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (NCHHSTP) Division of Tuberculosis Elimination (DTBE) convened a teleco...

File Type:

[PDF - 640.46 KB]
Recommendation for Using Smallpox Vaccine in a Pre-Event Vaccination Program : recommendations of the Advisory Committee on Immunization Practices (ACIP)

Personal Author:

Wharton, Melinda; Strikas, Raymond A.; Harpaz, Rafael; Rotz, Lisa D.; Schwartz, Benjamin; Casey, Christine G.; Pearson, Michele L.; Anderson, Larry J.;

Corporate Author:

United States. Advisory Committee on Immunization Practices.. Healthcare Infection Control Practices Advisory Committee (U.S.). National Center for Infectious Diseases (U.S.).

Published:

April 4, 2003

Source:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2003; 52(RR-7):1-16.

Description:

This report supplements the 2001 statement by the Advisory Committee on Immunization Practices (ACIP) (CDC. Vaccinia [smallpox] vaccine: recommendations of the Advisory Committee on Immunization Practices [ACIP], 2001. MMWR 2001;50[No. RR-10]:1-25). ...

Status:

current

File Type:

[PDF - 236.60 KB]
Commentary Considerations for Recommending Extended Use and Limited Reuse of Filtering Facepiece Respirators in Health Care Settings

Personal Author:

Fisher, Edward M.; Shaffer, Ronald E.;

Published:

2014

Source:

J Occup Environ Hyg. 11(8):D115-D128

Description:

Public health organizations, such as the Centers for Disease Control and Prevention (CDC), are increasingly recommending the use of N95 filtering facepiece respirators (FFRs) in health care settings. For infection control purposes, the usual practice...

File Type:

[PDF - 270.30 KB]